Astera Labs Inc’s recently made public that its Officer PHILIP MAZZARA acquired Company’s shares for reported $2.26 million on May 19 ’25. In the deal valued at $90.56 per share,25,000 shares were bought.
Then, HURLSTON MICHAEL E. sold 2,500 shares, generating $228,907 in total proceeds. Upon selling the shares at $91.56, the Director now owns 89,294 shares.
Before that, Mohan Jitendra sold 75,000 shares. Astera Labs Inc shares valued at $6,817,740 were divested by the Chief Executive Officer at a price of $90.90 per share. As a result of the transaction, Mohan Jitendra now holds 562,500 shares, worth roughly $50.79 million.
Susquehanna initiated its Astera Labs Inc [ALAB] rating to a Neutral in a research note published on May 16, 2025; the price target was $80. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid May from “an Equal-weight” to “an Overweight”. Raymond James began covering ALAB with “an Outperform” recommendation on March 14, 2025. Northland Capital revised its rating on January 28, 2025. It rated ALAB as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of ALAB
On Monday, Astera Labs Inc [NASDAQ:ALAB] saw its stock fall -0.30% to $90.29. Over the last five days, the stock has gained 12.46%. Astera Labs Inc shares have fallen nearly -31.83% since the year began. Nevertheless, the stocks have risen 16.62% over the past one year.
How much short interest is there in Astera Labs Inc?
A steep rise in short interest was recorded in Astera Labs Inc stocks on 2025-04-30, dropping by 63017.0 shares to a total of 10.76 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 10.82 million shares. There was a decline of -0.59%, which implies that there is a negative sentiment for the stock.
